glp 1 for premenopausal woman Postmenopausal women on the GLP-1 medication tirzepatide (Zepbound) obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 Semaglutide and Menopause: Does It

5.3 Lean Mass and Body Composition Weight loss trials indicate that: 2040% of weight lost may include lean mass, depending on protein intake and physical activity. Lean mass loss itself does not cause micronutrient deficiency, but it may reflect: Reduced protein intake Reduced intake of iron- and zinc-rich foods Reduced intake of B vitamins Clinical oversight of protein intake is therefore a practical nutritional priority

doi:10.1016/j.nutres.2020.08.008

(2025, August 8)

The Physician Perspective As a double board-certified internist and obesity-medicine specialist, I fully support advancing medical sciencebut only when its guided by rigorous research, regulatory oversight, and patient safety